ERSP gives Swiss Labs go-ahead with changes
This article was originally published in The Tan Sheet
Executive Summary
The Electronic Retailing Self-Regulation Program gives thumbs up to Swiss Labs for substantiating most claims for its Arthi-Zen Relief Dietary Supplement, but asks the firm to modify certain statements. ERSP says July 9 the marketer's clinical study supported general efficacy claims for the reduction of joint and muscle discomfort, but asks the firm to remove mention of "clinical studies" because there is only one. The group also asked Swiss Labs to modify the "immediate" relief claim because the study suggested most saw improvement after four days, and to modify the context of the claim "24-Hour Joint Relief" to explain that users "can experience relief for up to 24 hours in between dosages." Swiss Labs said it will comply. ERSP reviewed the Kankakee, Ill.-based firm's ads in ongoing monitoring